"Dodgy 6As": Differentiating pneumococcal serotype 6C from 6A by use of the Quellung reaction by Hare, Kim M. et al.
  Published Ahead of Print 8 April 2009. 
10.1128/JCM.00046-09. 
2009, 47(6):1981. DOI:J. Clin. Microbiol. 
Park, Moon H. Nahm and Amanda J. Leach
Kim M. Hare, Heidi Smith-Vaughan, Michael Binks, In Ho
 
Quellung Reaction
Serotype 6C from 6A by Use of the 
''Dodgy 6As'': Differentiating Pneumococcal
http://jcm.asm.org/content/47/6/1981
Updated information and services can be found at: 
These include:
REFERENCES
http://jcm.asm.org/content/47/6/1981#ref-list-1
This article cites 9 articles, 3 of which can be accessed free at: 
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 Septem
ber 30, 2013 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 o
n
 Septem
ber 30, 2013 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 o
n
 Septem
ber 30, 2013 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
JOURNAL OF CLINICAL MICROBIOLOGY, June 2009, p. 1981–1982 Vol. 47, No. 6
0095-1137/09/$08.000 doi:10.1128/JCM.00046-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
“Dodgy 6As”: Differentiating Pneumococcal Serotype 6C from 6A
by Use of the Quellung Reaction
The Quellung reaction has long been the standard method
for pneumococcal serotyping (7); however, the new serotype
6C is reportedly indistinguishable from serotype 6A using this
method (8). We report an anomalous Quellung reaction asso-
ciated with serotype 6C, which may aid in diagnostic interpre-
tation.
The 7-valent pneumococcal conjugate vaccine was intro-
duced in Australia for indigenous and other high-risk infants
in 2001. In 2002, a serotyping anomaly was noted in a subset
of carriage isolates. These isolates appeared negative for all
nine pool antisera A to I (covering 90 pneumococcal sero-
types) but reacted positively with Omni serum. Following
advice from the Pneumococcal Reference Laboratory in
Queensland, Australia, we found that these isolates reacted
strongly with group 6 antiserum but that factor reactions
were weak. Group 6 is included in the B pool. A selection of
isolates was sent to Queensland and serotyped as 6A. In
2003, the Statens Serum Institute (SSI) confirmed 10 such
isolates as 6A; pool B reactions were mostly weak (), while
pool Q reactions were strongly positive (). (Pool Q,
which includes group 6, is part of an alternative set of
antisera used to identify types present in the 23-valent pneu-
mococcal polysaccharide vaccine.) To distinguish “normal”
6As with strong pool B reactions, we referred to isolates
with weak or apparent negative pool B reactions as “dodgy”
6As.
In 2007, when the new serotype 6C was announced (8), we
queried whether our dodgy 6As were actually 6Cs. Using a
wciN PCR (9), we revealed that 1 of 20 prevaccine isolates
recorded as 6A was 6C, while 17 of 18 postvaccine isolates
recorded as 6A were 6C, suggesting serotype replacement. All
17 postvaccine serotype 6C isolates had been recorded as
dodgy 6As, while the one postvaccine serotype 6A isolate was
recorded as a normal 6A. Atypical reactions had not been
recorded prevaccine.
To confirm our results, fresh serum broths were prepared
and serotyped blinded. All 20 isolates typed as 6A by PCR
were normal 6As by the Quellung reaction, while all 18
isolates typed as 6C by PCR were dodgy 6As by the Quel-
lung reaction. Subsequently, another 144 6A isolates from a
2003 to 2005 surveillance study were tested using wciN PCR.
All 61 normal 6As were confirmed as 6A, while all 83 dodgy
6As were 6Cs. We have therefore matched PCR results to
pool B reactions for 182 isolates previously recorded as 6A
(81 [100%] normal 6A isolates were confirmed as serotype
6A by PCR and 101 [100%] dodgy 6A isolates were deter-
mined to be 6C by PCR).
We have used five different batches of pool B antiserum
since 2002; thus, batch variation is unlikely to have influ-
enced our findings. Furthermore, in a competitive inhibition
enzyme-linked immunosorbent assay, 6C polysaccharide an-
tigen did not significantly attenuate the binding of pool B to
6A and 6B polysaccharide antigens. This suggests that pool
B may react weakly with serotype 6C. Interestingly, 6C an-
tigen considerably inhibited the binding of pool Q to these
antigens, suggesting a strong pool Q reaction with 6C (as
reported by SSI).
The Quellung reaction is produced using the Neufeld test,
described by Lund (6) and Austrian (1), and the SSI pneu-
mococcal antisera insert (August 2001 revision). Briefly, a
drop of specimen is mixed with a drop of typing serum, a
coverslip is placed over the mixture, and the preparation is
examined using a 100 magnification oil immersion lens. A
positive reaction occurs when type-specific antibody binds to
the pneumococcal capsule, causing a change in its refractive
index so that it appears “swollen” and more visible. A World
Health Organization working group acknowledged the
Quellung reaction as the standard method for serotyping
pneumococcal isolates but did not detail a recommended
method (7).
FIG. 1. Quellung reaction photographed using a 100 magnifica-
tion oil-immersion lens, giving an appearance similar to that seen at
40 magnification. (a) 6A pool B reaction (normal); (b) 6C pool B
reaction (dodgy); (c) 6C negative control (no antiserum added).
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Recently, 11 reference laboratories in Europe partici-
pated in the validation of pneumococcal serotyping (5). A
high degree of consensus was found between the Neufeld
test and other serotyping methods (agglutination or gel dif-
fusion). Six laboratories used the Neufeld test; however, the
magnification used was not specified, nor was the use of oil
immersion (5). Australian laboratories routinely use 40
magnification (4), which is quicker and simpler than 100.
This protocol is accurate and reliable and has been used by
experts for more than 30 years (2). According to Henrichsen
(3), the Quellung reaction continues to be carried out es-
sentially as described by Austrian, and we find no reference
to any modified Neufeld method used outside Australia.
To our eyes, the differing strengths of the pool B reaction
with 6A and 6C were clearly visible at both magnifications
(Fig. 1). Furthermore, this phenomenon is not confined to
pool B antiserum. We have observed that a strong positive
pool G reaction indicates serotype 29 or 35B, while a weak
positive pool G reaction invariably indicates serotype 34.
We have demonstrated that pneumococcal serotype 6C is
associated with a weak pool B reaction which differentiates
it from 6A. This information should prove useful for labo-
ratories that use the Quellung reaction, particularly those
without the capability for molecular typing.
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